TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

SELEGILINE HYDROCHLORIDE

SELEGILINE HYDROCHLORIDE
Approved 1989-06-05
Jump to: Indications Approvals Trials Competitors Safety Patents
12
Indications
--
Phase 3 Trials
1
Priority Reviews
36
Years on Market

Details

Status
Discontinued
First Approved
1989-06-05
Routes
ORAL
Dosage Forms
CAPSULE, TABLET

Companies

LANNETT CO INC CHARTWELL MOLECULES I3 PHARMS KENTON Apotex QUAGEN RISING G AND W LABS INC NOVITIUM PHARMA COSETTE
Active Ingredient: SELEGILINE HYDROCHLORIDE

SELEGILINE HYDROCHLORIDE Approval History

Loading approval history...

What SELEGILINE HYDROCHLORIDE Treats

12 FDA approvals

Originally approved for its first indication in 1989 . Covers 12 distinct patient populations.

  • Other (12)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

SELEGILINE HYDROCHLORIDE FDA Label Details

Pro

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

FDA Approval: ANDA075145 → Patents: FDA Orange Book → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.